NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of Moderate Buy from Brokerages

Shares of NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target […]

Related Keywords

United States ,Martha Morrell ,Nantahala Capital Management ,Wells Fargo Company ,Cantor Fitzgerald ,Neuropace Inc ,Kent Lake Capital ,Millennium Management ,Securities Exchange Commission ,Nasdaq ,Morgan Stanley ,Jpmorgan Chase Co ,Get Free Report ,Street Capital ,Wells Fargo ,Exchange Commission ,Lake Capital ,Capital Management ,Get Free ,Neuropace Daily ,Neuropace ,Nasdaq Npce ,Npce ,Medical ,Ratings ,Consensus ,